Human Pathology
Volume 40, Issue 12 , Pages 1738-1746 , December 2009

Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status

  • Valeria Barresi, MD

      Affiliations

    • Department of Human Pathology, University of Messina, 98125 Messina, Italy
    • Corresponding Author InformationCorresponding author. Department Human Pathology, Policlinico Universitario G. Martino, Pad D, 98125 Messina, Italy.
  • ,
  • Francesca Romana Buttarelli, BBs

      Affiliations

    • Department of Experimental Medicine, University of Rome La Sapienza, 00185 Rome, Italy
  • ,
  • Enrica Vitarelli E, Bbs

      Affiliations

    • Department of Human Pathology, University of Messina, 98125 Messina, Italy
  • ,
  • Antonella Arcella, Bbs

      Affiliations

    • IRCCS Neuromed, 86077 Pozzilli (Is), Italy
  • ,
  • Manila Antonelli, MD

      Affiliations

    • Department of Experimental Medicine, University of Rome La Sapienza, 00185 Rome, Italy
  • ,
  • Felice Giangaspero, MD

      Affiliations

    • Department of Experimental Medicine, University of Rome La Sapienza, 00185 Rome, Italy
    • IRCCS Neuromed, 86077 Pozzilli (Is), Italy

Received 6 February 2009 ,Revised 23 March 2009 ,Accepted 13 April 2009.

References 

  1. Scherer PE, Lewis RY, Volontè D, Engelman JA, Galbiati F, Couet J. Cell-type and tissue-specific expression of caveolins-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 1997;272:29337–29346
  2. Cameron P, Ruffin JW, Bollag R, Rasmussen H, Cameron RS. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci. 1997;17:9520–9535
  3. Galbiati F, Volonte D, Gil O, et al. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci U S A. 1998;95:10257–10262
  4. Mikol DD, Hong HL, Cheng HL, Feldman EL. Caveolin-1 expression in Schwann cells. Glia. 1999;27:39–52
  5. Razani B, Engelman JA, Wang XB, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem. 2001;276:38121–38138
  6. Lee H, Volonte D, Galbiati F, et al. Constitutive and growth factor–regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol. 2000;14:1750–1775
  7. Fine SW, Lisanti MP, Galbiati F, Li M. Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol. 2001;115:719–724
  8. Kato K, Hida Y, Miyamoto M, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 2002;94:929–933
  9. Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC. Combined c-myc and caveolins-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer. 2005;103:1186–1194
  10. Barresi V, Cerasoli S, Paioli G, et al. Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropathol. 2006;112:617–626
  11. Barresi V, Cerasoli S, Tuccari G. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology. 2008;28:472–478
  12. Boon K, Edwards JB, Eberhart CG, Riggins GJ. Identification of astrocytoma associated genes including cell surface markers. BMC Cancer. 2004;4:39
  13. Cassoni P, Senetta R, Castellano I, et al. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas. Am J Surg Pathol. 2007;31:760–769
  14. Nigro JM, Misra A, Zhang L, et al. Integrated array comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res. 2005;65:1678–1686
  15. Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 2000;60:6617–6622
  16. Martin S, Cosset EC, Terrand J, Maglott A, Takeda K, Dontenwill M. Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist. Biochim Biophys Acta. 1793;2009:354–367
  17. Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A. Meningiomas. In:  Louis DN,  Ohgaki H,  Wiestler OD,  Cavenee WK editor. WHO classification of tumors of the central nervous system. Lyon: IARC Press; 2007;p. 25–85
  18. Weir EE, Pretlow TG, Pitts A. A more sensitive and specific histochemical peroxidase stain for the localization of cellular antigen by the enzyme-antibody conjugate method. J Histochem Cytochem. 1974;22:1135–1140
  19. Miyanaga T, Hirato J, Nakazato Y. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method. Neuropathology. 2008;28:116–126
  20. Silva WI, Maldonado HM, Lisanti MP, et al. Identification of caveolae and caveolin in C6 glioma cells. Int J Dev Neurosci. 1999;17:705–714
  21. Cameron PL, Liu C, Smart DK, Hantus ST, Fick JR, Cameron SR. Caveolin-1 expression is maintained in rat and human astroglioma cell lines. Glia. 2002;37:275–290
  22. Forget MA, Desrosiers RR, Del M, et al. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis. 2002;19:9–15
  23. Abulrob A, Giuseppin S, Andrade MF, McDermid A, Moreno M, Stranimirovic D. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveole. Oncogene. 2004;23:6967–6979
  24. Silva WI, Maldonado HM, Velazquez G. Caveolin isoform expression during differentiation of C6 glioma cells. Int J Dev Neurosci. 2005;23:599–612
  25. Ichimura K, Ohgaki H, Kleihues P, Collins VP. Molecular pathogenesis of astrocytic tumours. J Neurooncol. 2004;70:137–160
  26. Tanase CP. Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev Mol Diagn. 2008;8:395–404
  27. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A. 1987;84:6899–6903
  28. Fuller GN, Bigner SH. Amplified cellular oncogenes in neoplasms of the central nervous system. Mutat Res. 1992;276:299–306
  29. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem. 1997;272:30429–30438
  30. Park SS, Kim JE, Kim YA, Kim YC, Kim SW. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology. 2005;47:625–630
  31. Jarvella S, Helin H, Haapasalo J, et al. Amplification of the epidermal growth factor receptor in astrocytic tumors by chromogenic in situ hybridization: association with clinico-pathologic features and patient survival. Neuropathol Appl Neurobiol. 2006;32:441–450
  32. Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res. 1996;56:3859–3861
  33. Bogler O, Huang HJ, Kleihues P, Cavenee WK. The p53 gene and its role in human brain tumors. Glia. 1995;15:308–327
  34. Bist A, Fielding CJ, Fielding PE. P53 regulates gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry. 2000;39:1966–1972
  35. Ohgaki H, Dessen P, Joude B, et al. Kleihues P. genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64:6892–6899

 Dedicated to my son Alessandro on the occasion of his birth.

PII: S0046-8177(09)00195-6

doi: 10.1016/j.humpath.2009.04.026

Human Pathology
Volume 40, Issue 12 , Pages 1738-1746 , December 2009